| 000 | 01629 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250515110401.0 | ||
| 264 | 0 | _c20080703 | |
| 008 | 200807s 0 0 eng d | ||
| 022 | _a0066-4804 | ||
| 024 | 7 |
_a10.1128/AAC.01367-07 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPolhemus, Mark E | |
| 245 | 0 | 0 |
_aMalaria treatment with atovaquone-proguanil in malaria-immune adults: implications for malaria intervention trials and for pre-exposure prophylaxis of malaria. _h[electronic resource] |
| 260 |
_bAntimicrobial agents and chemotherapy _cApr 2008 |
||
| 300 |
_a1493-5 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Randomized Controlled Trial; Research Support, U.S. Gov't, Non-P.H.S. | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntimalarials _xtherapeutic use |
| 650 | 0 | 4 |
_aAtovaquone _xtherapeutic use |
| 650 | 0 | 4 | _aChemoprevention |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aKaplan-Meier Estimate |
| 650 | 0 | 4 | _aKenya |
| 650 | 0 | 4 |
_aMalaria Vaccines _xadministration & dosage |
| 650 | 0 | 4 |
_aMalaria, Falciparum _xdrug therapy |
| 650 | 0 | 4 |
_aParasitemia _xdrug therapy |
| 650 | 0 | 4 |
_aPlasmodium falciparum _xdrug effects |
| 650 | 0 | 4 |
_aProguanil _xtherapeutic use |
| 650 | 0 | 4 | _aTime Factors |
| 700 | 1 | _aRemich, Shon | |
| 700 | 1 | _aOgutu, Bernhards | |
| 700 | 1 | _aWaitumbi, John | |
| 700 | 1 | _aLievens, Marc | |
| 700 | 1 | _aBallou, W Ripley | |
| 700 | 1 | _aHeppner, D Gray | |
| 773 | 0 |
_tAntimicrobial agents and chemotherapy _gvol. 52 _gno. 4 _gp. 1493-5 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1128/AAC.01367-07 _zAvailable from publisher's website |
| 999 |
_c17773217 _d17773217 |
||